Note: After November 1, 2024, this dataset will no longer be updated due to a transition in NHSN Hospital Respiratory Data reporting that occurred on Friday, November 1, 2024. For more information on NHSN Hospital Respiratory Data reporting, please visit https://www.cdc.gov/nhsn/psc/hospital-respiratory-reporting.html.

Due to a recent update in voluntary NHSN Hospital Respiratory Data reporting that occurred on Wednesday, October 9, 2024, reporting levels and other data displayed on this page may fluctuate week-over-week beginning Friday, October 18, 2024. For more information on NHSN Hospital Respiratory Data reporting, please visit https://www.cdc.gov/nhsn/psc/hospital-respiratory-reporting.html. Find more information about the updated CMS requirements: https://www.federalregister.gov/documents/2024/08/28/2024-17021/medicare-and-medicaid-programs-and-the-childrens-health-insurance-program-hospital-inpatient. 

This dataset represents weekly respiratory virus-related hospitalization data and metrics aggregated to national and state/territory levels reported during two periods: 1) data for collection dates from August 1, 2020 to April 30, 2024, represent data reported by hospitals during a mandated reporting period as specified by the HHS Secretary; and 2) data for collection dates beginning May 1, 2024, represent data reported voluntarily by hospitals to CDC’s National Healthcare Safety Network (NHSN). NHSN monitors national and local trends in healthcare system stress and capacity for up to approximately 6,000 hospitals in the United States. Data reported represent aggregated counts and include metrics capturing information specific to COVID-19- and influenza-related hospitalizations, hospital occupancy, and hospital capacity. Find more information about reporting to NHSN at: https://www.cdc.gov/nhsn/psc/hospital-respiratory-reporting.html.

Source: COVID-19 hospitalization data reported to CDC’s National Healthcare Safety Network (NHSN).

• Data source description (updated October 18, 2024): As of October 9, 2024, Hospital Respiratory Data (HRD; formerly Respiratory Pathogen, Hospital Capacity, and Supply data or ‘COVID-19 hospital data’) are reported to HHS through CDC’s National Healthcare Safety Network based on updated requirements from the Centers for Medicare and Medicaid Services (CMS). These data are voluntarily reported to NHSN as of May 1, 2024 until November 1, 2024, at which time CMS will require acute care and critical access hospitals to electronically report information via NHSN about COVID-19, Influenza, and RSV, hospital bed census and capacity, and limited patient demographic information, including age. Data for collection dates prior to May 1, 2024, represent data reported during a previously mandated reporting period as specified by the HHS Secretary. Data for collection dates May 1, 2024, and onwards represent data reported voluntarily to NHSN; as such, data included represents reporting hospitals only for a given week and might not be complete or representative of all hospitals. NHSN monitors national and local trends in healthcare system stress and capacity for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN represent aggregated counts and include metrics capturing information specific to hospital capacity, occupancy, hospitalizations, and admissions. Find more information about reporting to NHSN: https://www.cdc.gov/nhsn/psc/hospital-respiratory-reporting.html. Find more information about the updated CMS requirements: https://www.federalregister.gov/documents/2024/08/28/2024-17021/medicare-and-medicaid-programs-and-the-childrens-health-insurance-program-hospital-inpatient. 
• Data quality: While CDC reviews reported data for completeness and errors and corrects those found, some reporting errors might still exist within the data. CDC and partners work with reporters to correct these errors and update the data in subsequent weeks. Data since December 1, 2020, have had error correction methodology applied; data prior to this date may have anomalies that are not yet resolved. Data prior to August 1, 2020, are unavailable.
• Metrics and inclusion criteria: Many hospital subtypes, including acute care and critical access hospitals, are included in the metric calculations included in this dataset. Psychiatric, rehabilitation, and religious non-medical hospital types, as well as Veterans Administration, Defense Health Agency, and Indian Health Service hospitals, are excluded from calculations. For a given metric calculation, hospitals that reported those data at least one day during a given week are included.
• Find full details on NHSN Hospital Respiratory Data (HRD) reporting guidance, including additional information on bed type definitions at https://www.cdc.gov/nhsn/psc/hospital-respiratory-reporting.html.

Notes: May 10, 2024: Due to missing hospital data for the April 28, 2024 through May 4, 2024 reporting period, data for Commonwealth of the Northern Mariana Islands (CNMI) are not available for this period in the Weekly NHSN Hospitalization Metrics report released on May 10, 2024.

May 17, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), Minnesota (MN), and Guam (GU) for the May 5,2024 through May 11, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on May 1, 2024.

May 24, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), and Minnesota (MN) for the May 12, 2024 through May 18, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on May 24, 2024.

May 31, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Virgin Islands (VI), Massachusetts (MA), and Minnesota (MN) for the May 19, 2024 through May 25, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on May 31, 2024.

June 7, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Virgin Islands (VI), Massachusetts (MA), Guam (GU), and Minnesota (MN) for the May 26, 2024 through June 1, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on June 7, 2024.

June 14, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), American Samoa (AS), and Minnesota (MN) for the June 2, 2024 through June 8, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on June 14, 2024.

June 21, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), West Virginia (WV), Massachusetts (MA), American Samoa (AS), Guam (GU), Virgin Islands (VI), and Minnesota (MN) for the June 9, 2024 through June 15, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on June 21, 2024.

June 28, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), American Samoa (AS), Virgin Islands (VI), and Minnesota (MN) for the June 16, 2024 through June 22, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on June 28, 2024.

July 5, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), West Virginia (WV), Massachusetts (MA), American Samoa (AS), Virgin Islands (VI), and Minnesota (MN) for the June 23, 2024 through June 29, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on July 5, 2024.

July 12, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), West Virginia (WV), Massachusetts (MA), American Samoa (AS), Virgin Islands (VI), and Minnesota (MN) for the June 30, 2024 through July 6, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on July 12, 2024.

July 19, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), American Samoa (AS), Virgin Islands (VI), and Minnesota (MN) for the July 7, 2024 through July 13, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on July 19, 2024.

July 26, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), American Samoa (AS), Virgin Islands (VI), and Minnesota (MN) for the July 13, 2024 through July 20, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on July 26, 2024.

August 2, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), American Samoa (AS), Virgin Islands (VI), West Virginia (WV), and Minnesota (MN) for the July 21, 2024 through July 27, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on August 2, 2024.

August 9, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), Guam (GU), American Samoa (AS), Virgin Islands (VI), and Minnesota (MN) for the July 28, 2024 through August 3, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on August 9, 2024.

August 16, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), American Samoa (AS), Virgin Islands (VI), and Minnesota (MN) for the August 4, 2024 through August 10, 2024 reporting period are not available for the Weekly NHSN Hospitalization Metrics report released on August 16, 2024.

August 23, 2024: Data for Commonwealth of the Northern Mariana Islands (CNMI), Massachusetts (MA), American Samoa (AS), Virgin Islands (VI), and Minnesota (MN) for the August 11, 2024 through August 17, 2024 reporting period are not available for the Weekly

According to the number of hospital discharges during fiscal year 2020 in the state of Massachusetts, normal neonate births were, by far, the most common condition for hospital stays.

In 2022, there were, on average, 2.35 hospital beds per 1,000 population in the United States. Hospital bed density varied widely between the states, with South Dakota having 4.61 beds per thousand population, while there were just 1.6 hospital beds per thousand population available in Washington.

In 2022, community hospitals in the United States had an average of 2.4 beds per 1,000 persons. The share of community hospital beds ranged from 1.6 to five beds per 1,000 persons across the country. The number of community hospital beds per 1,000 population in the United States decreased slightly from 2000 to 2022.

A model to predict the mass flows and concentrations of pharmaceuticals predominantly used in hospitals across a large number of sewage treatment plant (STP) effluents and river waters was developed at high spatial resolution. It comprised 427 geo-referenced hospitals and 742 STPs serving 98% of the general population in Switzerland. In the modeled base scenario, domestic, pharmaceutical use was geographically distributed according to the population size served by the respective STPs. Distinct hospital scenarios were set up to evaluate how the predicted results were modified when pharmaceutical use in hospitals was allocated differently; for example, in proportion to number of beds or number of treatments in hospitals. The hospital scenarios predicted the mass flows and concentrations up to 3.9 times greater than in the domestic scenario for iodinated X-ray contrast media (ICM) used in computed tomography (CT), and up to 6.7 times greater for gadolinium, a contrast medium used in magnetic resonance imaging (MRI). Field measurements showed that ICM and gadolinium were predicted best by the scenarios using number of beds or treatments in hospitals with the specific facilities (i.e., CT and/or MRI). Pharmaceuticals used both in hospitals and by the general population (e.g., cyclophosphamide, sulfamethoxazole, carbamazepine, diclofenac) were predicted best by the scenario using the number of beds in all hospitals, but the deviation from the domestic scenario values was only small. Our study demonstrated that the bed number-based hospital scenarios were effective in predicting the geographical distribution of a diverse range of pharmaceuticals in STP effluents and rivers, while the domestic scenario was similarly effective on the scale of large river-catchments.

This point layer contains the hospitals within the City of Cambridge.Explore all our data on the Cambridge GIS Data Dictionary.Attributes NameType DetailsDescription SITE_NAME type: Stringwidth: 50precision: 0 Facility name

ADDRESS type: Stringwidth: 40precision: 0 Facility address

PHONE type: Stringwidth: 16precision: 0 Main phone number of the facility

EditDate type: Stringwidth: 4precision: 0

This is a legacy dataset containing the name, address, neighborhood, and coordinates of hospital locations throughout the City.

The medical bed market is projected to surpass a valuation of US$ 5,469.0 million by 2033. Our healthcare analysts opine that medical bed manufacturers can expect a CAGR of 4.2% through 2033, with a current valuation of US$ 3,611.9 million in 2023.

Attributes	Details
Medical Bed Market Size, 2022	US$ 3,482.6 million
Medical Bed Market Size, 2023	US$ 3,611.9 million
Medical Bed Market Size, 2033	US$ 5,469.0 million
Value CAGR (2023 to 2033)	4.2%

Historical Performance of the Medical Bed Market (2018 to 2022) Vs. Forecast Outlook (2023 to 2033)

Attributes	Details
Medical Bed Market Size (2018)	US$ 2,998.6 million
Medical Bed Market Size (2022)	US$ 3,482.6 million
Medical Bed Market (CAGR 2018 to 2022)	3.6%

Category-wise Insights

Segment	Intensive Care (Application)
Value Share (2023)	49.8%

Segment	Electric Beds (Bed Type)
Value Share (2023)	33.4%

Country-wise Insights

Countries	Value CAGR (2023 to 2033)
United States	3.8%
Germany	2.8%
India	5.4%
China	6.1%
Japan	3.8%

0 (Number) in 2013.

The size and share of the market is categorized based on Type (In-building Mass Notification System, Outdoor Mass Notification System, Distributed or Hybrid Mass Notification System) and Application (Hospitals, Clinics, Nursing Home, Long Term Care, Ambulatory Surgical Centres (ASC?s)) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

This dataset is about book subjects and is filtered where the books is The Massachusetts General Hospital review of critical care medicine, featuring 10 columns including authors, average publication date, book publishers, book subject, and books. The preview is ordered by number of books (descending).

Adult psychiatry is an important part of medical and mental health treatments in the U.S. As of 2024, the top hospital for adult psychiatry was Massachusetts General Hospital in Boston, Massachusetts, with a score of 14 percent. The score represents the percentage of surveyed psychiatric specialists that named select hospitals as the best for challenging patients. Despite hospitals having a wider range of care options for patients, a majority of the mental health treatment facilities in the U.S. are listed as outpatient care centers without day treatment options or partial hospitalization options. Mental Health in the U.S. In the U.S. millions of people are affected by mental illness every year. Mental illnesses can range from mood disorders such as depression and bipolar disorder to schizophrenia and anxiety disorders. Research has indicated that as of 2022 up to a quarter of adults between the ages of 18 and 25 in the U.S. had experienced some sort of mental illness within the past year, with rates of mental illness decreasing with age. A recent survey also indicated that among adults in the U.S. those living in Oregon and Utah may have the poorest mental health status among all states. Mental Health Treatment in the U.S. Not all mental health treatment requires hospitalization or psychiatric treatment. Most mental health issues can be addressed and treated in individual or group psychotherapy, but treatment differs drastically based on the type of mental illness. Psychotherapy, medication, case management, hospitalization and support groups are just a few of the ways mental illness can be treated. As of 2023 a larger percentage of U.S. adults utilized prescription medications as opposed to any other kind of therapy. Among adults that sought treatment from a professional for a major depressive episode, a majority had seen a general practitioner or family doctor to treat their mental health issues.

2 (Number) in 2013.

The map provides a filterable database to help the public find urgent care locations in their community that offer specific services, service times, or accept their insurance type. Urgent care centers are for mild illnesses and minor injuries.

Snapshot img

Medical Mattresses Market 2024-2028

The global medical mattresses market size is estimated to grow by USD 3.81 billion at a CAGR of 4.91% between 2023 and 2028.

Spread of infectious diseases such as tuberculosis (TB) and COVID-19 is anticipated to increase the demand for medical mattresses across the globe. Furthermore, an increase in the prevalence of infectious diseases drives admission rates in healthcare facilities. To meet the high demand from healthcare facilities, manufacturers and suppliers are introducing advanced products and increasing market penetration through efficient distribution networks. The rising incidence of infectious diseases has prompted suppliers and manufacturers to expand their market reach and enter emerging markets. Hence, these factors will also drive market growth during the forecast period.It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the size of the Medical Mattresses Market During the Forecast Period?

Request Free Sample

Market Segmentation

The medical mattresses market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.

End-user Outlook

  Commercial
  Residential





Product Outlook

  Foam
  Innerspring
  Others





Region Outlook

  North America

    The U.S.
    Canada





  Europe

    The U.K.
    Germany
    France
    Rest of Europe





  Asia

    China
    India





  Rest of the World (ROW)

    Argentina
    Australia
    Brazil 

End-user Analysis

The market share growth by the commercial segment will be significant during the forecast period. The commercial segment includes end-users, including hospitals, healthcare providers, and rehabilitation facilities. These mattresses are specifically engineered to provide optimal support and comfort to patients during a variety of medical procedures, after-care, or for those with pre-existing medical conditions.

Get a glance at the market contribution of various segments Download PDF Sample

The commercial segment was valued at USD 9.59 billion in 2018. Medical mattresses are utilized in healthcare settings to enhance patient comfort during medical examinations, treatments, and monitoring procedures. Additionally, these mattresses may be designed with specific features, such as additional firmness and dynamic pressure redistribution, to meet the specific requirements of patients in rehabilitation programs. Hence, such factors under the commercial end-user segment will boost the growth of the global medical mattresses market during the forecast period. Moreover, advancements in antimicrobial medical textiles used in these mattresses are enhancing infection control and hygiene standards in healthcare settings. These textiles incorporate antimicrobial properties to inhibit the growth of bacteria and pathogens, thereby reducing the risk of healthcare-associated infections. The integration of antimicrobial medical textiles in medical mattresses underscores the industry's commitment to enhancing patient safety and comfort, which further supports the market's growth trajectory.

Product Analysis

Foam

Foam mattresses are made with various layers of foam, such as memory foam, or even more specially designed foam, such as viscoelastic foam. These layers of foam mold to the patient's body shape and distribute their weight evenly. The foam's ability to align with the body's contours helps to keep the spine in proper alignment, reducing pain and complications. Medical mattresses made from foam are renowned for their strength and durability, making them an economical choice for healthcare settings. Hence, these advantages and features will raise the demand for foam as a product segment and will consequently drive the growth of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download the PDF Sample now!

Asia is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The medical mattresses market in Asia is driven by the increasing number of hospitals, clinics, and diagnostic centers, the growing geriatric population, and the rising prevalence of chronic diseases in the region.

Moreover, an increase in the number of hospital beds in developed and developing countries such as Japan and South Korea and rising healthcare expenditure are factors that are expected to drive the growth of the market in the region. Furthermore, manufacturers and suppliers of medical mattresses are shifting their production facilities and ma